7 results match your criteria: "IRCCS Azienda Ospedaliero-Universitaria di Bologna S. Orsola Hospital[Affiliation]"

Article Synopsis
  • Visceral leishmaniasis (VL) is a serious disease increasingly seen in northern Italy, especially in children and those with weakened immune systems.
  • A study at St. Orsola University Hospital analyzed 16 hospitalized children over nine years, revealing that most presented with fever, low blood cell counts, and swollen spleens; treatments with Liposomal Amphotericin B effectively managed symptoms.
  • Pediatricians should consider VL as a potential diagnosis for children with unexplained fever and related symptoms, using abdominal ultrasounds and blood tests for diagnosis instead of invasive procedures like bone marrow aspiration.
View Article and Find Full Text PDF

Registry of Aortic Diseases to Model Adverse Events and Progression (ROADMAP) in Uncomplicated Type B Aortic Dissection: Study Design and Rationale.

Radiol Cardiothorac Imaging

December 2022

Center for Academic Medicine, Department of Radiology (D.M., M.J.W., V.L.T., V.H., M.C., A.M.S., K.B., D.F.), Stanford Cardiovascular Institute (D.M., M.P.F., D.F.), and Department of Cardiothoracic Surgery (D.C.M., M.P.F.), Stanford University School of Medicine, 453 Quarry Rd, MC 5659, Palo Alto, CA 94304-5659; Departments of Medical Imaging (K.H.) and Surgery (M.O.), Toronto General Hospital, University of Toronto, Toronto, Canada; Department of Radiology (D.O.T.) and Department of Cardiothoracic and Vascular Surgery (R.O.A.), McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, Tex; Department of Radiology, Massachusetts General Hospital, Boston, Mass (S.H.); Departments of Radiology (N.S.B.) and Cardiac Surgery (B.Y.), University of Michigan, Ann Arbor, Mich; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pa (J.M.L.); Division of Cardiac Surgery, University of Maryland, Baltimore, Md (T.G.G.); Departments of Cardiac Surgery (D.P., G.F.) and Radiology (L.L.), IRCCS Azienda Ospedaliero-Universitaria di Bologna S. Orsola Hospital, Bologna, Italy; Department of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland (R.H., H.A.); Department of Radiology and Imaging Sciences, Emory University, Atlanta, Ga (A.E.S.); Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC (E.P.C.); and Department of Clinical Epidemiology and Medical Technology Assessment (S.M.J.v.K.) and Department of Surgery (G.W.H.S.), Maastricht University Medical Center, Maastricht, the Netherlands.

Purpose: To describe the design and methodological approach of a multicenter, retrospective study to externally validate a clinical and imaging-based model for predicting the risk of late adverse events in patients with initially uncomplicated type B aortic dissection (uTBAD).

Materials And Methods: The Registry of Aortic Diseases to Model Adverse Events and Progression (ROADMAP) is a collaboration between 10 academic aortic centers in North America and Europe. Two centers have previously developed and internally validated a recently developed risk prediction model.

View Article and Find Full Text PDF

Bone health in transgender people: a narrative review.

Ther Adv Endocrinol Metab

May 2022

Division of Gynecology and Physiopathology of Human Reproduction, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria Di Bologna. S. Orsola Hospital, University of Bologna, Via Massarenti 13, 40138.

Bone health in transmen and transwomen is an important issue that needs to be evaluated by clinicians. Prior to gender-affirming hormone treatment (GAHT), transwomen have lower bone mineral density (BMD) and a higher prevalence of osteopenia than cismen probably related to external factors, such as hypovitaminosis D and less physical activities. Gonadotropin-releasing hormone (GnRH) analogues in transgender youth may cause bone loss; however, the addition of GAHT restores or at least improves BMD in both transboys and transgirls.

View Article and Find Full Text PDF

Accuracy of cytological examination of Tao brush endometrial sampling in diagnosing endometrial premalignancy and malignancy.

Int J Gynaecol Obstet

December 2022

Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, Baronissi, Italy.

Although Tao brush has become one of the most studied and used endometrial cytological samplers, concerns remain about the adequacy of the cytological sample compared with definitive histology. We aimed to assess accuracy of cytological examination from Tao brush sampling in diagnosing endometrial premalignancy and malignancy through a systematic review and meta-analysis. Seven electronic databases were searched from January 2000 to July 2021 for all studies which allowed assessment of accuracy of Tao brush in diagnosing endometrial premalignancy and malignancy.

View Article and Find Full Text PDF

Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients.

Int J Environ Res Public Health

March 2022

Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.

Background: In endometrial carcinoma (EC) patients, sentinel lymph node (SLN) biopsy has shown the potential to reduce post-operative morbidity and long-term complications, and to improve the detection of low-volume metastasis through ultrastaging. However, while it has shown high sensitivity and feasibility in low-risk EC patient groups, its role in high-risk groups is still unclear.

Aim: To assess the role of SLN biopsy through the cervical injection of indocyanine green (ICG) in high-risk groups of early-stage EC patients.

View Article and Find Full Text PDF

Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.

Gynecol Oncol

April 2022

Gynecology and Obstetrics Unit, Department of Medicine, Surgery and Dentistry "Schola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.

Background: The 2020 ESGO/ESTRO/ESP guidelines stratify the prognosis of endometrial carcinoma (EC) patients combining The Cancer Genome ATLAS (TCGA) molecular signature and pathological factors, including lymphovascular space invasion (LVSI). However, little is known about the prognostic independence of LVSI from molecular signature.

Aim: To assess whether the prognostic value of LVSI is independent from the TCGA signature.

View Article and Find Full Text PDF

Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.

Gynecol Oncol

August 2021

Division of Gynaecology and Human Reproduction Physiopathology, Department of Medical and Surgical Sciences (DIMEC)., IRCCS Azienda Ospedaliero-Universitaria di Bologna. S. Orsola Hospital. University of Bologna, Via Massarenti 13, Bologna 40138, Italy.

Background: 2021 ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma (EC) encourage molecular classification and propose a new prognostic risk stratification based on both pathologic and molecular features. Although deep myometrial invasion (DMI) has been considered as a crucial risk factor in EC, it is unclear if its prognostic value is independent from The Cancer Genome ATLAS (TCGA) groups.

Aim: To assess if the prognostic value of DMI is independent from the TCGA groups in EC patients.

View Article and Find Full Text PDF